Literature DB >> 2384010

Serum interleukin 2-receptor levels in uveitis.

E Arocker-Mettinger1, T Asenbauer, S Ulbrich, G Grabner.   

Abstract

This study reports on serum interleukin 2-receptor (IL-2R) levels in uveitis patients. IL-2R is the mediator protein of interleukin 2 (IL-2), a mitogenetic cytokine of primarily immune cell interaction. Stimulated T-cells readily express IL-2R on their cell surface and release a soluble form into serum. The measurement of IL-2R serum levels was performed using a monoclonal antibody based ELISA with age and sex matched healthy blood donors serving as the control group. The increase of IL-2R serum levels in patients affected by heterochromic cyclitis Fuchs (HCF) and a small group of children with chronic anterior uveitis affected by juvenile rheumatoid arthritis (JRA) was statistically highly significant, when compared to the control group (n = 84, alpha = 0.01). Serum levels of patients with intermediate uveitis (IU), patients with HLA-B27 positive acute anterior uveitis (AAU) and patients with HLA-B27 negative AAU did not differ significantly from the controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384010     DOI: 10.3109/02713689008999415

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  13 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 2.  Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms.

Authors:  E La Hey; P T de Jong; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

3.  Interleukin 4, IgG and oligoclonal IgG in aqueous humor of cataract patients.

Authors:  N Stambuk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

Review 4.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Authors:  R W J Lee; A D Dick
Journal:  Eye (Lond)       Date:  2011-09-30       Impact factor: 3.775

5.  Does autoimmunity to S-antigen play a role in Fuchs' heterochromic cyclitis?

Authors:  E La Hey; L Broersma; R van der Gaag; G S Baarsma; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

Review 6.  Genetic of uveitis.

Authors:  Francesco Pichi; Paola Carrai; Sunil K Srivastava; Careen Y Lowder; Paolo Nucci; Piergiorgio Neri
Journal:  Int Ophthalmol       Date:  2015-10-09       Impact factor: 2.031

7.  Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Larry B Vogler
Journal:  Int J Clin Rheumtol       Date:  2013-02-01

8.  Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis.

Authors:  Ming-ming Yang; Timothy Y Y Lai; Pancy O S Tam; Sylvia W Y Chiang; Carmen K M Chan; Fiona O J Luk; Tsz-Kin Ng; Chi-Pui Pang
Journal:  Mol Vis       Date:  2012-07-11       Impact factor: 2.367

9.  CFH 184G as a genetic risk marker for anterior uveitis in Chinese females.

Authors:  Ming-ming Yang; Timothy Y Y Lai; Pancy O S Tam; Sylvia W Y Chiang; Carmen K M Chan; Fiona O J Luk; Tsz Kin Ng; Chi-Pui Pang
Journal:  Mol Vis       Date:  2011-10-13       Impact factor: 2.367

Review 10.  Influence of molecular genetics in Vogt-Koyanagi-Harada disease.

Authors:  Joanne Yw Ng; Fiona Oj Luk; Timothy Yy Lai; Chi-Pui Pang
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.